Skip to main content
Clinical Trials/NCT00863967
NCT00863967
Unknown
Not Applicable

Prospective Observational Cohort Study for Early Detection of Arteriosclerosis

Kantonsspital Baselland Bruderholz0 sites269 target enrollmentOctober 2003

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Arteriosclerosis
Sponsor
Kantonsspital Baselland Bruderholz
Enrollment
269
Primary Endpoint
Cardiovascular events
Last Updated
17 years ago

Overview

Brief Summary

Arteriosclerosis is a common chronic disease with well known risk factors like diabetes mellitus, hypertension, dyslipidemia, adipositas and smoking, leading to severe complications like myocardial infarction, stroke or peripheral arterial occlusive disease. In addition to life-style factors there is also a genetic predisposition to develop complicated atherosclerosis.

Objective: Improve individual risk prediction by clinical phenotyping and genotyping.

Detailed Description

About 300 patients who are treated for various conditions at the department of general medicine at our hospital will be included prospectively in the study. This observational cohort will be followed for at least 10 years follow-up examinations. At baseline and during follow up visits detailed clinical phenotyping is planned (medical and family history,standardized clinical and physical examinations, lab, RX, ECG, stress-test or echocardiogram). The genotyping is performed by DNA-isolation from leucocytes collected at baseline.

Registry
clinicaltrials.gov
Start Date
October 2003
End Date
October 2015
Last Updated
17 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Kantonsspital Baselland Bruderholz

Eligibility Criteria

Inclusion Criteria

  • 18 years and older
  • informed consent

Exclusion Criteria

  • life-threatening disease
  • life expectancy \< 1 month
  • uncapable to provide informed consent

Outcomes

Primary Outcomes

Cardiovascular events

Time Frame: 10 years at least

Secondary Outcomes

  • Disease activity score(2 / 5 / 10 years)

Similar Trials